Form 8-K - Current report:
SEC Accession No. 0001193125-20-296976
Filing Date
2020-11-18
Accepted
2020-11-18 16:19:54
Documents
14
Period of Report
2020-11-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d48144d8k.htm   iXBRL 8-K 24280
2 EX-99.1 d48144dex991.htm EX-99.1 17838
6 GRAPHIC g48144g1119011133251.jpg GRAPHIC 3729
  Complete submission text file 0001193125-20-296976.txt   172057

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lnth-20201118.xsd EX-101.SCH 3070
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20201118_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20201118_pre.xml EX-101.PRE 10953
7 EXTRACTED XBRL INSTANCE DOCUMENT d48144d8k_htm.xml XML 3246
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 201325338
SIC: 2835 In Vitro & In Vivo Diagnostic Substances